- In August 2024, Terumo India, the Indian subsidiary of Japan-based Terumo Corporation, a global leader in medical technology, announced the launch of the TREO Stent-Graft System, an innovative solution for Endovascular Aneurysm Repair (EVAR)
- In July 2024, Endospan announced a new agreement with Artivion for additional loans totaling up to USD 25 million. Artivion, which operates in over 100 countries, offers a range of products including aortic stent grafts, surgical sealants, mechanical heart valves, and implantable cardiac and vascular human tissue. The funding aims to support Endospan’s efforts to secure FDA approval for its Nexus Stent Graft System
- In January 2024, W. L. Gore & Associates, Inc. (Gore) announced FDA approval for a lower-profile version of the GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX Stent Graft). This approval enhances a device already recognized as a vital tool for managing complex vascular diseases. The updated VBX Stent Graft features the longest balloon-expandable stent on the market (79 mm), the widest range of stent diameter adjustability, and the highest number of 6 Fr compatible configurations among balloon-expandable stent grafts
- In June 2023, Endospan shared the initial European experience with its NEXUS DUO Aortic Arch Stent Graft System at the Leipzig Interventional Course (LINC). The multicenter study showcased the first ten patients treated with this custom-made system
- In May 2021, Endologix LLC announced the first implant of its ALTO Abdominal Stent Graft in Canada following Health Canada approval. The device was also recently approved for commercial sale in Argentina
